| Company Name: | Bexil Corporation | | Ticker Symbol: | BXL | | | WWW Address: | www.bexil.com | | CEO: | Thomas B. Winmill, Esq. | | No. of Employees: | 1 | | Common Issue Type: | CS | | Business Description: | The Company engaged in the business of evaluating opportunities to develop and acquire long-term acute care hospitals.
|
| | | Industry Information: | DIVERSIFIED SERVICES - Business Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | |  | - | - | 0 | 31.00 | 31.00 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 27.4 | 0.9 | 0.08 | 24.23 | 1.00 | 155.0 | 0.0 | 34.40 - 25.93 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 31.00 | $ | | PE Ratio - LTM | 155.0 | |
| Market Capitalisation | 27.4 | mil |
| Latest Shares Outstanding | 0.9 | mil |
| Earnings pS (EPS) | 24.23 | $ |
| Dividend pS (DPS) | 1.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 4 | % |
| Revenue per Employee | 5,000 | $ |
| Effective Tax Rate | 36.1 | % |
| Float | 0.8 | mil |
| Float as % of Shares Outstanding | 93.0 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 602.20 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 0.0 | % |
| EBITDA Margin | 0.0 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 0.0 | % |
| Return on Assets (ROA) | 0.5 | % |
| Return on Equity (ROE) | 0.5 | % |
| Return on Capital Invested (ROCI) | 0.5 | % |
| Current Ratio | 155.7 | |
| Leverage Ratio (Assets/Equity) | 1.0 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 42.83 | $ |
| Cash pS | 0.70 | $ |
| Book-Value pS | 42.98 | $ |
| Tangible Book-Value pS | 42.98 | $ |
| Cash Flow pS | 25.24 | $ |
| Free Cash Flow pS | -57.20 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.72 | |
| Price/Tangible Book Ratio | 0.72 | |
| Price/Cash Flow | 1.2 | |
| Price/Free Cash Flow | -0.5 | |
| P/E as % of Industry Group | 477.0 | % |
| P/E as % of Sector Segment | 613.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 4.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.8 | 101 | 12 | 7 |
| 4 Weeks | 32.51 | 27.59 | 32.20 | -3.7 | 93 | 16 | 311 |
| 13 Weeks | 33.45 | 27.59 | 33.00 | -6.1 | 92 | 8 | 529 |
| 26 Weeks | 34.40 | 27.59 | 32.83 | -5.6 | 88 | 9 | 1,152 |
| 52 Weeks | 34.40 | 25.93 | 26.12 | 18.7 | 104 | 11 | 2,775 |
| YTD | 34.40 | 27.59 | - | -6.3 | 87 | 10 | 1,828 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 31.00 | 30.77 | 31.81 | 32.58 | 32.70 | 0.08 | -0.19 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 0.00 | 0.0 | 0.00 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | 0.00 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -100.0 | -100.0 | -98.4 |
| Earnings % | -99.7 | -99.6 | 1492.7 |
| EPS % | -99.7 | -99.6 | 1423.9 |
| EPS $ | -20.22 | -19.75 | 22.64 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 99.13 |
| Current Ratio | 183.5 |
| Quick Ratio (Acid Test) | 183.5 |
| Liquidity Ratio (Cash) | 178.68 |
| Receivables Turnover | 0.0 |
| Average Collection Period | 0 |
| Working Capital/Equity | 99.7 |
| Working Capital pS | 42.71 |
| Cash-Flow pS | 25.24 |
| Free Cash-Flow pS | -18.76 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 84.53 |
| Financial Leverage Ratio (Assets/Equity) | 1.0 |
| Debt Ratio | 0.5 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 0.0 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.24 |
| Tobin's Q Ratio | 0.72 |
| Current P/E Ratio - LTM | 155.00 |
| Enterprise Value (EV)/EBITDA | 2.71 |
| Enterprise Value (EV)/Free Cash Flow | 0.58 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 0.72 |
| Price/Book Ratio - LTM | 0.72 |
| Price/Cash Flow Ratio | 1.2 |
| Price/Free Cash Flow Ratio - LTM | -0.5 |
| Price/Sales Ratio | 47.69 |
| P/E Ratio (1 month ago) - LTM | 161.0 |
| P/E Ratio (26 weeks ago) - LTM | 1.4 |
| P/E Ratio (52 weeks ago) - LTM | 1.2 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 477.0 |
| P/E as % of Sector Segment | 613.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 1.3 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.23 |
| Tangible Book Value pS - LTM | 42.98 |
| Book Value pS - LTM | 42.98 |
| Capital Invested pS | 42.85 |
| Cash pS - LTM | 0.70 |
| Cash Flow pS - LTM | 25.24 |
| Free Cash Flow pS - LTM | -57.20 |
| Earnings pS (EPS) | 24.23 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -331,600.44 |
| Free Cash Flow Margin 5YEAR AVG | -109,701.50 |
| Net Profit Margin | 0.0 |
| Net Profit Margin - 5YEAR AVRG. | 0.0 |
| Equity Productivity | 0.00 |
| Return on Equity (ROE) | 58.9 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 0.00 |
| Return on Capital Invested (ROCI) | 58.9 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 0.0 |
| Assets Productivity | 0.00 |
| Return on Assets (ROA) | 58.6 |
| Return on Assets (ROA) - 5YEAR AVRG. | 0.0 |
| Gross Profit Margin | 0.0 |
| Gross Profit Margin - 5YEAR AVRG. | 0.0 |
| EBITDA Margin - LTM | 0.0 |
| EBIT Margin - LTM | 0.0 |
| Pre-Tax Profit Margin | 0.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 0.0 |
| Effective Tax Rate | 36.1 |
| Effective Tax Rate - 5YEAR AVRG. | 3.3 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 71,264 |
| Revenue per Employee | 5,000 |
| Net Income per Employee | 22,301,533 |
| Average Collection Period | 71,264 |
| Receivables Turnover | 0.0 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 4,136.58 |
| Assets/Revenue | 0.00 |
| Net Working Capital Turnover | 0.00 |
| Fixed Assets Turnover | 0.04 |
| Total Assets Turnover | 0.0 |
| Revenue per $ Cash | 0.01 |
| Revenue per $ Plant | 0.00 |
| Revenue per $ Common Equity | 0.00 |
| Revenue per $ Capital Invested | 0.00 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 69046.6 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |